These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9663919)

  • 1. Angiotensin converting enzyme inhibition and calcium antagonism attenuate streptozotocin-diabetes-associated mesenteric vascular hypertrophy independently of their hypotensive action.
    Cao Z; Hulthén UL; Allen TJ; Cooper ME
    J Hypertens; 1998 Jun; 16(6):793-9. PubMed ID: 9663919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular hypertrophy and albumin permeability in a rat model combining hypertension and diabetes mellitus. Effects of calcium antagonism, angiotensin converting enzyme inhibition, and angiotensin II-AT1-receptor blockade.
    Hulthén UL; Cao Z; Rumble JR; Cooper ME; Johnston CI
    Am J Hypertens; 1996 Sep; 9(9):895-901. PubMed ID: 8879346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinins or nitric oxide, or both, are involved in the antitrophic effects of angiotensin converting enzyme inhibitors on diabetes-associated mesenteric vascular hypertrophy in the rat.
    Rumble JR; Komers R; Cooper ME
    J Hypertens; 1996 May; 14(5):601-7. PubMed ID: 8762203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of calcium channel blockade or angiotensin-converting enzyme inhibition on structure of coronary, renal, and other small arteries in spontaneously hypertensive rats.
    Li JS; Schiffrin EL
    J Cardiovasc Pharmacol; 1996 Jul; 28(1):68-74. PubMed ID: 8797138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular hypertrophy in diabetic spontaneously hypertensive rats: optimizing blockade of the renin-angiotensin system.
    Lassila M; Davis BJ; Allen TJ; Burrell LM; Cooper ME; Cao Z
    Clin Sci (Lond); 2003 Apr; 104(4):341-7. PubMed ID: 12653675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined blockade of AT1-receptors and ACE synergistically potentiates antihypertensive effects in SHR.
    Raasch W; Jöhren O; Schwartz S; Gieselberg A; Dominiak P
    J Hypertens; 2004 Mar; 22(3):611-8. PubMed ID: 15076168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes-associated mesenteric vascular hypertrophy is attenuated by angiotensin-converting enzyme inhibition.
    Cooper ME; Rumble J; Komers R; Du HC; Jandeleit K; Chou ST
    Diabetes; 1994 Oct; 43(10):1221-8. PubMed ID: 7926292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin converting enzyme inhibition reduces the expression of transforming growth factor-beta1 and type IV collagen in diabetic vasculopathy.
    Rumble JR; Gilbert RE; Cox A; Wu L; Cooper ME
    J Hypertens; 1998 Nov; 16(11):1603-9. PubMed ID: 9856360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of angiotensin II and bradykinin in experimental diabetic nephropathy. Functional and structural studies.
    Allen TJ; Cao Z; Youssef S; Hulthen UL; Cooper ME
    Diabetes; 1997 Oct; 46(10):1612-8. PubMed ID: 9313758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrepant regulation of QT (QTc) interval duration by calcium channel blockade and angiotensin converting enzyme inhibition in experimental hypertension.
    Klimas J; Vaja V; Vercinska M; Kyselovic J; Krenek P
    Basic Clin Pharmacol Toxicol; 2012 Oct; 111(4):279-88. PubMed ID: 22626243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of dietary salts on the cardiovascular effects of low-dose combination of ramipril and felodipine in spontaneously hypertensive rats.
    Mervaala EM; Malmberg L; Teräväinen TL; Laakso J; Vapaatalo H; Karppanen H
    Br J Pharmacol; 1998 Jan; 123(2):195-204. PubMed ID: 9489606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bradykinin and matrix metalloproteinases are involved the structural alterations of rat small resistance arteries with inhibition of ACE and NEP.
    Rizzoni D; Rossi GP; Porteri E; Sticchi D; Rodella L; Rezzani R; Sleiman I; De Ciuceis C; Paiardi S; Bianchi R; Nussdorfer GG; Agabiti-Rosei E
    J Hypertens; 2004 Apr; 22(4):759-66. PubMed ID: 15126918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of the arterial internal elastic lamina by inhibition of the renin-angiotensin system in the rat.
    Huang W; Alhenc Gelas F; Osborne-Pellegrin MJ
    Circ Res; 1998 May; 82(8):879-90. PubMed ID: 9576107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic vascular hypertrophy and albuminuria: effect of angiotensin converting enzyme inhibition.
    Allen TJ; Hulthen UL; Rumble JR; Jasik M; Cooper ME
    J Diabetes Complications; 1995; 9(4):318-22. PubMed ID: 8573756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme inhibition reduces diabetes-induced vascular hypertrophy: morphometric studies.
    Vranes D; Cooper ME; Dilley RJ
    J Vasc Res; 1995; 32(3):183-9. PubMed ID: 7772678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural changes and cyclic GMP content of the aorta after calcium antagonism or angiotensin converting enzyme inhibition in renovascular hypertensive rats.
    Véniant M; Gray GA; Heudes D; Ménard J; Clozel JP
    J Hypertens; 1995 Jul; 13(7):731-7. PubMed ID: 7594436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular and cardiac protection by ramipril in spontaneously hypertensive rats: prevention versus regression study.
    Gohlke P; Linz W; Schölkens B; Van Even P; Martorana P; Unger T
    Br J Clin Pract Suppl; 1996 Jul; 84():1-10. PubMed ID: 8994995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
    Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T
    Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term low-dose angiotensin converting enzyme inhibitor treatment increases vascular cyclic guanosine 3',5'-monophosphate.
    Gohlke P; Lamberty V; Kuwer I; Bartenbach S; Schnell A; Linz W; Schölkens BA; Wiemer G; Unger T
    Hypertension; 1993 Nov; 22(5):682-7. PubMed ID: 8225528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of candesartan cilexetil and enalapril on structural alterations and endothelial function in small resistance arteries of spontaneously hypertensive rats.
    Rizzoni D; Porteri E; Bettoni G; Piccoli A; Castellano M; Muiesan ML; Pasini G; Guelfi D; Rosei EA
    J Cardiovasc Pharmacol; 1998 Nov; 32(5):798-806. PubMed ID: 9821855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.